SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-23-019766
Filing Date
2023-02-13
Accepted
2023-02-13 16:45:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G tm236576d1_sc13g.htm SC 13G 34059
  Complete submission text file 0001104659-23-019766.txt   35554
Mailing Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027
Business Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 (650) 331-9090
AN2 Therapeutics, Inc. (Subject) CIK: 0001880438 (see all company filings)

IRS No.: 820606654 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93617 | Film No.: 23619287
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE CITY CENTER 110 CORCORAN STREET DURHAM NC 27701
Business Address ONE CITY CENTER 110 CORCORAN STREET DURHAM NC 27701 (734)730-7256
Brii Biosciences Ltd (Filed by) CIK: 0001965619 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G